Biotage AB (publ) (STO:BIOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
141.60
+0.20 (0.14%)
May 9, 2025, 9:00 AM CET
-16.26%
Market Cap 11.32B
Revenue (ttm) 1.96B
Net Income (ttm) 255.00M
Shares Out 80.05M
EPS (ttm) 3.18
PE Ratio 44.48
Forward PE 47.49
Dividend 1.65 (1.17%)
Ex-Dividend Date Apr 25, 2025
Volume 225
Average Volume 1,181,836
Open 141.40
Previous Close 141.40
Day's Range 141.40 - 141.60
52-Week Range 81.60 - 202.20
Beta 0.89
RSI 77.92
Earnings Date Jul 16, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts... [Read more]

Sector Healthcare
Founded 1969
Employees 680
Stock Exchange Nasdaq Stockholm
Ticker Symbol BIOT
Full Company Profile

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial Statements